Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 2
2009 2
2010 3
2011 1
2012 2
2013 1
2014 1
2015 1
2016 4
2017 2
2018 5
2019 3
2020 4
2021 5
2022 1
2023 1
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial.
Furie RA, Aroca G, Cascino MD, Garg JP, Rovin BH, Alvarez A, Fragoso-Loyo H, Zuta-Santillan E, Schindler T, Brunetta P, Looney CM, Hassan I, Malvar A. Furie RA, et al. Among authors: fragoso loyo h. Ann Rheum Dis. 2022 Jan;81(1):100-107. doi: 10.1136/annrheumdis-2021-220920. Epub 2021 Oct 6. Ann Rheum Dis. 2022. PMID: 34615636 Free PMC article. Clinical Trial.
Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
Morand EF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C, Bae SC, Brohawn PZ, Pineda L, Berglind A, Tummala R; TULIP-2 Trial Investigators. Morand EF, et al. N Engl J Med. 2020 Jan 16;382(3):211-221. doi: 10.1056/NEJMoa1912196. Epub 2019 Dec 18. N Engl J Med. 2020. PMID: 31851795 Clinical Trial.
Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.
Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D, Li LS, Mysler E, Sánchez-Guerrero J, Solomons N, Wofsy D; Aspreva Lupus Management Study Group. Appel GB, et al. J Am Soc Nephrol. 2009 May;20(5):1103-12. doi: 10.1681/ASN.2008101028. Epub 2009 Apr 15. J Am Soc Nephrol. 2009. PMID: 19369404 Free PMC article. Clinical Trial.
Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.
Dooley MA, Jayne D, Ginzler EM, Isenberg D, Olsen NJ, Wofsy D, Eitner F, Appel GB, Contreras G, Lisk L, Solomons N; ALMS Group. Dooley MA, et al. N Engl J Med. 2011 Nov 17;365(20):1886-95. doi: 10.1056/NEJMoa1014460. N Engl J Med. 2011. PMID: 22087680 Free article. Clinical Trial.
First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR).
Pons-Estel BA, Bonfa E, Soriano ER, Cardiel MH, Izcovich A, Popoff F, Criniti JM, Vásquez G, Massardo L, Duarte M, Barile-Fabris LA, García MA, Amigo MC, Espada G, Catoggio LJ, Sato EI, Levy RA, Acevedo Vásquez EM, Chacón-Díaz R, Galarza-Maldonado CM, Iglesias Gamarra AJ, Molina JF, Neira O, Silva CA, Vargas Peña A, Gómez-Puerta JA, Scolnik M, Pons-Estel GJ, Ugolini-Lopes MR, Savio V, Drenkard C, Alvarellos AJ, Ugarte-Gil MF, Babini A, Cavalcanti A, Cardoso Linhares FA, Haye Salinas MJ, Fuentes-Silva YJ, Montandon de Oliveira E Silva AC, Eraso Garnica RM, Herrera Uribe S, Gómez-Martín D, Robaina Sevrini R, Quintana RM, Gordon S, Fragoso-Loyo H, Rosario V, Saurit V, Appenzeller S, Dos Reis Neto ET, Cieza J, González Naranjo LA, González Bello YC, Collado MV, Sarano J, Retamozo S, Sattler ME, Gamboa-Cárdenas RV, Cairoli E, Conti SM, Amezcua-Guerra LM, Silveira LH, Borba EF, Pera MA, Alba Moreyra PB, Arturi V, Berbotto GA, Gerling C, Gobbi CA, Gervasoni VL, Scherbarth HR, Brenol JCT, Cavalcanti F, Costallat LTL, Da Silva NA, Monticielo OA, Seguro LPC, Xavier RM, Llanos C, Montúfar Guardado RA, Garcia de la Torre I, Pineda C, Portela Hernández M, Danza A, Guibert-Toledano M, Re… See abstract for full author list ➔ Pons-Estel BA, et al. Among authors: fragoso loyo h. Ann Rheum Dis. 2018 Nov;77(11):1549-1557. doi: 10.1136/annrheumdis-2018-213512. Epub 2018 Jul 25. Ann Rheum Dis. 2018. PMID: 30045853 Free PMC article.
Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries.
Bolla E, Semb AG, Kerola AM, Ikdahl E, Petri M, Pons-Estel GJ, Karpouzas GA, Sfikakis PP, Quintana R, Misra DP, Borba EF, Garcia-de la Torre I, Popkova TV, Artim-Esen B, Troldborg A, Fragoso-Loyo H, Ajeganova S, Yazici A, Aroca-Martinez G, Direskeneli H, Ugarte-Gil MF, Mosca M, Goyal M, Svenungsson E, Macieira C, Hoi A, Lerang K, Costedoat-Chalumeau N, Tincani A, Mirrakhimov E, Acosta Colman I, Danza A, Massardo L, Blagojevic J, Yılmaz N, Tegzová D, Yavuz S, Korkmaz C, Hachulla E, Moreno Alvarez MJ, Muñoz-Louis R, Pantazis N, Tektonidou MG; SURF-SLE and APS collaborators. Bolla E, et al. Among authors: fragoso loyo h. Lancet Rheumatol. 2024 Jul;6(7):e447-e459. doi: 10.1016/S2665-9913(24)00090-0. Epub 2024 Jun 12. Lancet Rheumatol. 2024. PMID: 38878780
Distribution and characteristics of the certification of rheumatologists in Mexico.
Álvarez-Hernández E, Barreira-Mercado E, Fragoso-Loyo HE, Hernández-Díaz C, Mota-Mondragón B, Muñoz-López S, Pérez-Cristóbal M, Rubio-Pérez N, Torres-Jiménez A, Vargas Guerrero A, Vázquez Del Mercado M, Villarreal-Alarcón MÁ, Pacheco-Tena C, Alpízar-Rodríguez D. Álvarez-Hernández E, et al. Among authors: fragoso loyo he. Reumatol Clin (Engl Ed). 2023 Aug-Sep;19(7):379-385. doi: 10.1016/j.reumae.2023.04.002. Epub 2023 May 6. Reumatol Clin (Engl Ed). 2023. PMID: 37156651 Free article.
Clinical Practice Mexican Guidelines for the Treatment of Systemic Lupus Erythematosus: 2024 Update.
Andrade-Ortega L, Xibillé-Friedmann D, Galarza-Delgado DA, Saavedra MÁ, Alvarez-Nemegyei J, Amigo-Castañeda MC, Fragoso-Loyo H, Gordillo-Huerta MV, Irazoque-Palazuelos F, Jara-Quezada LJ, Merayo-Chalico J, Portela-Hernández M, Sicsik-Ayala S, Abud-Mendoza C, Alpizar-Rodriguez D, Amaya-Estrada JL, Barragán-Navarro YR, Carrillo-Vázquez SM, Castro-Colín Z, Cruz-Álvarez LJ, Durán-Barragán S, Esquivel-Valerio JA, Gamez-Nava JI, García-García C, Gonzalez-Lopez L, Hadid-Smeke J, Hernández-Bedolla A, Hernández-Cabrera MF, Herrera-VanOostdam DA, Horta-Baas G, Iturbide-Escamilla AE, Muñoz-Lopez S, Pacheco-Tena C, Pérez-Cristóbal M, Pimentel-Leon RR, Pinto-Ortiz M, Ramos-Sánchez MA, Sandoval-Cabrera DV, de Anda KS, Silveira LH, Barile-Fabris LA. Andrade-Ortega L, et al. Among authors: fragoso loyo h. Reumatol Clin (Engl Ed). 2024 Nov;20(9):490-510. doi: 10.1016/j.reumae.2024.10.003. Epub 2024 Nov 5. Reumatol Clin (Engl Ed). 2024. PMID: 39505612 Free article.
High Mortality of COVID-19 in Young Mexican Patients With Rheumatic Diseases: Comparative Analysis Versus the General Population.
Martínez-Martínez MU, Colunga-Pedraza IJ, Irazoque-Palazuelos F, Reyes-Cordero G, Rodriguez-Reyna TS, Veloz-Aranda JA, Skinner-Taylor CM, Juárez-Mora IM, Silveira LH, Zazueta-Montiel BE, Castillo-Ortiz AA, Martínez A, Zamora-Tehozol E, Maya-Piña LV, Perez-Barbosa L, Galarza-Delgado DA, Hernandez MDC, Marquez-Miranda O, Andrade-Ortega L, Fuentes-Hernandez MN, Morales DV, Aguiar MC, Oostdam DAH, Loredo-Alanis SA, Martín-Nares E, Durán-Barragán S, Jiménez-Jiménez X, Vázquez-Del Mercado M, Moctezuma-Rios JF, Rull-Gabayet M, Barragán-Garfías JA, Tena CFP, Xibille-Friedmann DX, Alpizar-Rodriguez D; Mexican Study Group of COVID-19 in Rheumatic Diseases. Martínez-Martínez MU, et al. J Clin Rheumatol. 2024 Aug 1;30(5):e143-e148. doi: 10.1097/RHU.0000000000002086. Epub 2024 May 16. J Clin Rheumatol. 2024. PMID: 38753050 No abstract available.
40 results